Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mycophenolate mofetil therapy for severe immune thrombocytopenia.

British journal of haematology·2015
Same author

A curious case of haemolysis, seizure and acute renal failure associated with pregnancy.

Journal of nephrology·2014
Same author

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2013
Same author

Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.

European journal of haematology·2013
Same author

Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia.

Expert opinion on biological therapy·2013
Same author

Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonist.

Expert opinion on drug discovery·2013

Related Experiment Video

Updated: May 16, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

How to approach thrombocytopenia.

Roberto Stasi1

  • 1Department of Haematology, St Georges Hospital, London, United Kingdom. roberto.stasi@stgeorges.nhs.uk

Hematology. American Society of Hematology. Education Program
|December 13, 2012
PubMed
Summary

Thrombocytopenia, a low platelet count, can signal infections like HIV or serious conditions like thrombotic microangiopathies. Identifying the cause is key for effective patient management and treatment.

Area of Science:

  • Hematology
  • Internal Medicine
  • Clinical Diagnostics

Background:

  • Thrombocytopenia (low platelet count) is a frequent hematologic finding.
  • It presents with diverse clinical manifestations, ranging from asymptomatic cases to life-threatening conditions.
  • It can be an early indicator of infections (e.g., HIV, hepatitis C) or severe disorders (e.g., thrombotic microangiopathies).

Purpose of the Study:

  • To provide a systematic approach for evaluating adults with thrombocytopenia.
  • To differentiate diagnostic strategies for outpatients versus emergency/intensive care unit settings.
  • To discuss common etiologies of thrombocytopenia in different clinical scenarios.

Main Methods:

  • Systematic review of adult thrombocytopenia evaluations.

More Related Videos

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Related Experiment Videos

Last Updated: May 16, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

  • Comparative analysis of diagnostic approaches based on patient setting (outpatient vs. acute care).
  • Discussion of prevalent causes of low platelet counts.

    • Main Results:

    • Diagnostic strategies vary significantly between asymptomatic outpatients and critically ill patients requiring immediate intervention.
    • Common causes of thrombocytopenia include infections and thrombotic microangiopathies.
    • Prompt identification of etiology is critical for appropriate management.

    Conclusions:

    • A tailored diagnostic approach is essential for effective thrombocytopenia management.
    • Distinguishing between outpatient and acute settings guides the selection of diagnostic tests.
    • Understanding common etiologies aids in timely and accurate diagnosis.